MEDIANA i25 Body Composition Analyzer
KSh900,000.00
Mediana i25 Body Composition Analyzer is a reliable and cost-effective patient monitor designed to provide accurate and comprehensive vital signs for patients in various clinical settings.
- Description
- Specifications
- Reviews (0)
- Documentation
Description
Mediana i25 Body Composition Analyzer is a reliable and cost-effective patient monitor designed to provide accurate and comprehensive vital signs for patients in various clinical settings.
Features
- Multi-Frequency Analysis Technology (10, 50, 100kHz) and Segmental Body Composition Analysis
- Easy operation via touch screen (4.3inch) and simple interface
- Body Composition Analysis: Total Body Water, Muscle Mass, Fat Mass, Fat Free Mass, Protein, Mineral, Skeletal Muscle
- Skeletal Muscle & Body Fat Analysis: Weight, Skeletal Muscle Mass, Body Fat Mass Assessment
- Segmental Analysis: Segmental Muscle, Fat and Body Balance Assessment
- Weight Control: BMI, Obesity Degree, Desirable Weight, Weight/Fat/Muscle mass Control
- Visceral Fat & Abdominal Fat Ratio Assessment
- Intake & Consumed Calories: BMR, Total Energy Expenditure, Calorie Consumption, and Expected Fat Burning
- Mediana Score, Segmental Weight and Impedance, Calorie Consumption Table per Exercise, QR code for Mobile App
Applications
It is used in hospitals, gyms, nursing homes and schools to analyzing , measuring, and monitoring essential body composition parameters based on bioelectrical impedance analysis (BIA) person.
Additional information
Brand | |
---|---|
Display Type | Customized LCD |
Power | Power Input AC 100~240V, 50/60Hz, 1.2A,Power Output DC 12V, 3.33A |
Interface | Mini USB, RS-232C 1EA, USB |
Application Areas | Health and Fitness Centers, Hospitals, Hospitals (dialysis),medical research centres, Medical centers,sports medicine, medical research,fitness centers, Medical research centers, Schools |
Be the first to review “MEDIANA i25 Body Composition Analyzer”
You must be logged in to post a review.
Reviews
There are no reviews yet.